Chief Clinical Operations Officer

• Jan 2022 - Present

CLIA Laboratory Director

• Feb 2018 - Present

Laboratory Director of a high-throughput, high-complexity, CLIA/CAP molecular laboratory. California Laboratory Director License #DRN01014799

VP Clinical Operations

• Aug 2017 - Dec 2021

Responsible for laboratory operations, R&D, clinical interpretation and reporting, genetic counseling, customer support, and executive leadership of the organization. Developed, launched and established FDA EUA for high-throughput COVID (SARS-CoV-2) testing laboratory.Color provides distributed healthcare services to drive public health initiatives. Color has established secure and HIPAA compliant tools to onboard, consent and engage large populations; handle logistics for distributed biospecimen collection; process samples through high-throughput CLIA/CAP clinical testing laboratories; and integrate with EMRs and state and federal reporting systems. Show less

co-Principal Investigator

• Aug 2019 - Present

Responsible for return of results, genetic counseling, and reporting and engagement software infrastructure for the 1M participants of the All of Us Research Program. 1OT2OD028251-01 Responsible for return of results, genetic counseling, and reporting and engagement software infrastructure for the 1M participants of the All of Us Research Program. 1OT2OD028251-01

co-Principal Investigator

• Sep 2018 - Present

Responsible for genome sequencing, clinical interpretation and reporting of incidental findings to the 1M participants of the All of Us Research Program. 1OT2OD002750-01 Responsible for genome sequencing, clinical interpretation and reporting of incidental findings to the 1M participants of the All of Us Research Program. 1OT2OD002750-01

Head of Clinical Genomics / Clinical Molecular Geneticist

• Apr 2013 - Jul 2017

Lead a team of 50 scientists, genetic counselors and clinical area directors that work on understanding and communicating the clinical meaning of genetic information. Guide the development of processes and approaches for variant interpretation and reporting. Envision and guide the development of infrastructure and software to support thorough, efficient and reproducible work. Lead a team of 50 scientists, genetic counselors and clinical area directors that work on understanding and communicating the clinical meaning of genetic information. Guide the development of processes and approaches for variant interpretation and reporting. Envision and guide the development of infrastructure and software to support thorough, efficient and reproducible work.

Assistant Director, Molecular Diagnostic Laboratory

• 2012 - 2013

Led the development, implementation, validation, launch and operations of clinical next-generation sequencing. Clinical focus on the molecular diagnosis of brain malformations, rare neurodevelopmental disorders, and early infantile epilepsy. Led the development, implementation, validation, launch and operations of clinical next-generation sequencing. Clinical focus on the molecular diagnosis of brain malformations, rare neurodevelopmental disorders, and early infantile epilepsy.

ABMG Molecular Genetics Fellow

• 2010 - 2012

Post-doctoral fellow in Molecular Genetics (American Board of Medical Genetics approved training program). Focus on development of next-generation sequencing assays for the rapid diagnosis of neurological disease. Post-doctoral fellow in Molecular Genetics (American Board of Medical Genetics approved training program). Focus on development of next-generation sequencing assays for the rapid diagnosis of neurological disease.

Research Scientist

• 2005 - 2010

Systems approaches to identifying consequences and regulators of the cellular environmental stress response. Systems approaches to identifying consequences and regulators of the cellular environmental stress response.

Adjunct Faculty

• 2001 - 2003